According to Stryker Corporation's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.06925. At the end of 2023 the company had a P/S ratio of 5.55.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.55 | 10.68% |
2022 | 5.02 | -14.95% |
2021 | 5.90 | -8.1% |
2020 | 6.42 | 21.47% |
2019 | 5.28 | 22.42% |
2018 | 4.31 | -7.34% |
2017 | 4.66 | 17.55% |
2016 | 3.96 | 13.65% |
2015 | 3.49 | -5.43% |
2014 | 3.69 | 17.05% |
2013 | 3.15 | 30.84% |
2012 | 2.41 | 5.08% |
2011 | 2.29 | -20.18% |
2010 | 2.87 | -3.76% |
2009 | 2.98 | 24.17% |
2008 | 2.40 | -52.59% |
2007 | 5.06 | 18.87% |
2006 | 4.26 | 15.28% |
2005 | 3.70 | -18.89% |
2004 | 4.56 | -2.7% |
2003 | 4.68 | 5.7% |
2002 | 4.43 | 0.38% |
2001 | 4.41 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Medtronic MDT | 3.52 | -42.03% | ๐ฎ๐ช Ireland |
Baxter BAX | 1.20 | -80.17% | ๐บ๐ธ USA |
Boston Scientific BSX | 7.45 | 22.79% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 8.84 | 45.63% | ๐บ๐ธ USA |
Waters Corporation WAT | 7.23 | 19.18% | ๐บ๐ธ USA |
Integra LifeSciences IART | 1.41 | -76.85% | ๐บ๐ธ USA |
Smith & Nephew
SNN | 2.45 | -59.67% | ๐ฌ๐ง UK |
Owens & Minor
OMI | 0.1415 | -97.67% | ๐บ๐ธ USA |
Hill-Rom HRC | N/A | N/A | ๐บ๐ธ USA |